Understanding the critical components of a successful cleanroom and barrier isolator project

American Journal of Health-System Pharmacy

Volumn 57, Issue 4, 2000, Pages 346-350

  Rahe, Hank ^a  

^a Technical Advisor Containment Technologies Group   (United States)

Author keywords

Aseptic areas; Equipment; Pharmacists; Technology

Indexed keywords

AIR QUALITY; AIRBORNE PARTICLE; ARTICLE; CLEANING; CLINICAL LABORATORY; CONTAMINATION; DRUG SYNTHESIS; ENVIRONMENTAL MONITORING; FOOD AND DRUG ADMINISTRATION; PHARMACIST; PRIORITY JOURNAL; TECHNOLOGY; WORK ENVIRONMENT; WORKROOM AIR;

EID: 0034652168     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/57.4.346     Document Type: Article

References (11)

1. American Society of Hospital Pharmacists. ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products. Am J Hosp Pharm. 1993; 50:2386-98.
2. Sterile drug products for home use. Pharmacopeial Forum. 1995; 21:1587-602.
3. 21CFR 10.90. Guideline on sterile drug products produced by aseptic processing 1987 (currently under revision). Washington, DC: Food and Drug Administration; 1987.
4. Federal Standard 209E. Airborne particulate cleanliness classes in clean rooms and clean zones. Washington, DC: General Services Administration; 1992 Sep 11.
5. Cleanrooms and associated controlled environments. Part 4, design and construction. Geneva, Switzerland: International Organization of Standardization, 1998; TC 209.
6. Avis KE. Assuring the quality of pharmacy-prepared sterile products. Pharmaguide Hospital Med. 1996; 9(2).
7. 1999 ASHRAE handbook. Chap. 15. Clean spaces. Atlanta: American Society of Heating, Refrigerating, and Air-Conditioning Engineers; 1999.
8. IES-RP-CC012.1. Considerations in clean-room design. Section 5.6. Mount Prospect, IL: Institute of Environmental Sciences.
9. Cleanroom basics. Cleanrooms. 1998; 12(Dec suppl).
10. ISPE Barrier Isolation Technology Conference wrap-up. Pharm Eng. 1995; 15(Jan/ Feb):58.
11. Friedman RL. Compliance officer FDA. Design of barrier/isolators for aseptic processing: a GMP perspective. Pharm Eng. 1998; 18(Mar/Apr):28-36.